Recently, an ER-resident protein, malectin, was found to specifically recognize Glc 2 Man 9 GlcNAc 2 (G2M9) N-glycans (10) (11) (12) .
By analogy with two other ER-resident lectin chaperones, CNX and CRT, which specifically recognize mono-glucosylated Glc 1 Man 9 GlcNAc 2 (G1M9), malectin is thought to be involved in the quality control of glycoproteins. Indeed, we and others demonstrated that malectin was induced under conditions of ER stress and is preferentially associated with folding-defective glycoproteins (13, 14) . However, the molecular mechanisms by Ribophorin I is an ER-resident transmembrane protein, which serves as a subunit of the mammalian OST complex (15) . Recent studies show that ribophorin I regulates the glycosylation of some glycoproteins by selectively associating with, and delivering them to, the catalytic core of the OST complex (16, 17) . Association of ribophorin I with newly synthesized membrane proteins was observed after the exit of the nascent chain from the Sec61 translocon, and was unaffected by N-glycosylation status (18) . Myc-tag sequence as previously described (21) .
Plasmids for the expression of human malectin and its mutants, and AT and its variant, AT NHK , were prepared as described previously (14) . Therefore, other mechanisms must be responsible for selectivity. (Table 1) .
Protein identification by MALDI-TOF MS

Identification of malectin binding partners -
As an orthogonal test of protein identification, the co-immunoprecipitates were analyzed by western blotting using a specific antibody against ribophorin I ( Fig. 2A, lanes 3,4) . (Myc-OST48) (Fig. 4) . Both Myc-rpn2 and Myc-OST48 were co-precipitated with FLAG-mal and ribophorin I (Fig. 4B, panel a,   lanes 1 and 3) . However, knockdown of ribophorin I using specific siRNA dramatically abrogated co-precipitation of both Myc-rpn2
and Myc-OST48 (Fig. 4B, anti-AT antibodies (Fig. 5B) . In accordance with a previous study (14) , only the misfolded AT NHK (AT NHK * in Fig. 5B ), but not the wild-type AT, was co-precipitated by FLAG-mal (Fig. 5B, lane 3) . This was was further inhibited by ribophorin 1 co-expression (Fig. 5C, lane 3) , whereas, the secretion of wild-type AT was not markedly affected ( Fig. 5C , lanes 4-6). We also investigated the effects of ribophorin I overexpression upon DNJ treatment (Fig. 5D) .
DNJ, an inhibitor of GI and GII, preferentially inhibits the activity of GII when low concentrations (1 mM) are used (14) .
Interestingly, though further enhancement of AT NHK and malectin co-precipitation was not observed by overexpression of ribophorin I upon DNJ treatment (Fig. 5D, lanes 3 and 4) , the interaction between AT and malectin induced by DNJ treatment (Fig. 5D, lane 7) was inhibited by overexpression of ribophorin I ( These results were confirmed by the present study, which showed that malectin preferentially co-precipitated with misfolded AT NHK , but not with wild-type AT (Fig. 1) . However, the mechanism by which malectin preferentially (Fig. 1) . Second, we found that malectin formed a stable complex with ribophorin I ( (Fig. 7) . These findings suggest a potential mechanism whereby malectin preferentially associates with misfolded glycoproteins (Fig. 8) .
In our hypothesis, the initial interaction of nascent glycoproteins with malectin occurs through the binding of G2M9 glycans generated by glucosidase I. As shown in Malectin forms a complex with ribophorin I (Rpn1), which is one of the subunits of the oligosaccaryltransferase complex, (OST complex). Malectin specifically binds to G2M9 glycans, whereas ribophorin I preferentially binds to (i) unfolded or (ii) misfolded proteins. The lectin-like properties of malectin and the chaperone-like characteristics of ribophorin I may account for the stable association with misfolded glycoproteins. www.jbc.org
